Meeder Asset Management Inc Biomarin Pharmaceutical Inc Transaction History

Meeder Asset Management Inc

$1.48 Billion
Q3 2024

A detailed history of Meeder Asset Management Inc transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Meeder Asset Management Inc holds 735 shares of BMRN stock, worth $47,775. This represents 0.0% of its overall portfolio holdings.

Number of Shares

735

Previous 72 920.83%

Holding current value

$47,775

Previous $5,000 920.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	BUY	$69.02 - $93.84 $45,760 - $62,215	663 Added 920.83%	735 $51,000
Q2 2024 Aug 08, 2024	SELL	$74.43 - $92.22 $446 - $553	-6 Reduced 7.69%	72 $5,000
Q1 2024 May 07, 2024	BUY	$83.81 - $99.0 $6,537 - $7,722	78 New	78 $6,000
Q4 2022 Feb 14, 2023	BUY	$80.93 - $108.63 $323 - $434	4 New	4 $0
Q2 2022 Aug 08, 2022	SELL	$71.48 - $86.85 $2,644 - $3,213	-37 Closed	0 $0
Q1 2022 May 10, 2022	BUY	$74.28 - $92.69 $2,748 - $3,429	37 New	37 $3,000
Q4 2021 Feb 11, 2022	SELL	$71.72 - $91.47 $3,299 - $4,207	-46 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$74.77 - $85.47 $1,644 - $1,880	-22 Reduced 32.35%	46 $4,000
Q1 2021 Apr 28, 2021	SELL	$74.73 - $90.69 $1,868 - $2,267	-25 Reduced 26.88%	68 $5,000
Q4 2020 Feb 09, 2021	SELL	$72.61 - $90.2 $3,703 - $4,600	-51 Reduced 35.42%	93 $8,000
Q3 2020 Nov 02, 2020	SELL	$71.87 - $131.03 $1.17 Million - $2.14 Million	-16,295 Reduced 99.12%	144 $11,000
Q2 2020 Aug 11, 2020	BUY	$79.55 - $124.22 $1.11 Million - $1.73 Million	13,965 Added 564.47%	16,439 $2.03 Million
Q1 2020 May 15, 2020	BUY	$71.37 - $96.85 $16,986 - $23,050	238 Added 10.64%	2,474 $208,000
Q4 2019 Feb 13, 2020	BUY	$64.27 - $86.37 $117,485 - $157,884	1,828 Added 448.04%	2,236 $189,000
Q3 2019 Oct 17, 2019	BUY	$67.4 - $85.11 $11,660 - $14,724	173 Added 73.62%	408 $27,000
Q2 2019 Aug 05, 2019	BUY	$80.35 - $93.9 $18,882 - $22,066	235 New	235 $20,000
Q1 2019 Apr 16, 2019	SELL	$84.2 - $98.62 $17,766 - $20,808	-211 Closed	0 $0
Q4 2018 Jan 17, 2019	SELL	$80.14 - $106.07 $22,359 - $29,593	-279 Reduced 56.94%	211 $18,000
Q2 2018 Jul 24, 2018	SELL	$76.01 - $99.03 $2,812 - $3,664	-37 Reduced 7.02%	490 $0
Q4 2017 Feb 02, 2018	SELL	$80.76 - $95.13 $24,954 - $29,395	-309 Reduced 36.96%	527 $47,000
Q3 2017 Oct 20, 2017	BUY	$80.6 - $94.95 $67,381 - $79,378	836	836 $78,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Biomarin Pharmaceutical Inc Transaction History